Literature DB >> 12439312

Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study.

Olivier Vignaux1, Robin Dhote, Denis Duboc, Philippe Blanche, Jean-Yves Devaux, Simon Weber, P Legmann.   

Abstract

PURPOSE: To assess myocardial magnetic resonance imaging (MRI) findings in sarcoidosis.
METHODS: Cardiac assessment was prospectively performed in patients with sarcoidosis and included physical examination, electrocardiogram, echocardiography, thallium-201 myocardial scintigraphy, and coronary angiography if coronary disease was suspected. T2-weighted black-blood single-shot and inversion recovery fast spin echo, functional gradient echo, and T1-weighted gadolinium-DTPA-enhanced cardiac MRI examinations were performed in 40 patients while other cardiac disease was excluded.
RESULTS: Results of the MRI images were normal in cardiac-asymptomatic stage I or Lofgren syndrome patients (n = 4). Among the patients with cardiac-asymptomatic multiple organ sarcoidosis, 17 of 31 patients (54%) had MRI myocardial abnormalities similar to those observed in five patients with cardiac symptoms: nodular peripheral increased intramyocardial signal intensity on both T2-weighted and contrast-enhanced images (n = 5), focal or patchy increased signal on contrast-enhanced images with or without myocardial thickening (n = 10), and focal increased signal only on T2-weighted images with or without myocardial thinning (n = 2). Focal contractility abnormalities were noticed in nine patients.
CONCLUSIONS: These preliminary results emphasize the occurrence of subclinical myocardial MRI abnormalities in patients with ongoing systemic sarcoidosis.

Entities:  

Mesh:

Year:  2002        PMID: 12439312     DOI: 10.1097/00004728-200209000-00017

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  42 in total

1.  Cardiac sarcoidosis with a rare initial manifestation: sustained monomorphic ventricular tachycardia.

Authors:  Gautamy Chitiki Dhadham; Nishant Gupta; Rupen Parikh; Mahesh Bikkina
Journal:  Tex Heart Inst J       Date:  2011

2.  Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance.

Authors:  J Schulz-Menger; R Wassmuth; H Abdel-Aty; I Siegel; A Franke; R Dietz; M G Friedrich
Journal:  Heart       Date:  2006-03       Impact factor: 5.994

3.  Utility of endomyocardial biopsy guided by delayed enhancement areas on magnetic resonance imaging in the diagnosis of cardiac sarcoidosis.

Authors:  B Borchert; T Lawrenz; M Bartelsmeier; S Röthemeyer; H Kuhn; C Stellbrink
Journal:  Clin Res Cardiol       Date:  2007-08-21       Impact factor: 5.460

4.  Cardiac sarcoidosis: a challenge to measure disease activity.

Authors:  Ruth G M Keijsers; Fred J Verzijlbergen; Benno J W M Rensing; Jan C Grutters
Journal:  J Nucl Cardiol       Date:  2008-04-08       Impact factor: 5.952

Review 5.  Cardiac Applications of PET-MR.

Authors:  Peter J Bergquist; Michael S Chung; Anja Jones; Mark A Ahlman; Charles S White; Jean Jeudy
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 6.  Cardiac magnetic resonance imaging in heart failure: where the alphabet begins!

Authors:  Ahmed Aljizeeri; Abdulbaset Sulaiman; Naji Alhulaimi; Ahmed Alsaileek; Mouaz H Al-Mallah
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

Review 7.  Viewpoints in the diagnosis and treatment of cardiac sarcoidosis: Proposed modification of current guidelines.

Authors:  Dae-Won Sohn; Jun-Bean Park; Seung-Pyo Lee; Hyung-Kwan Kim; Yong-Jin Kim
Journal:  Clin Cardiol       Date:  2018-10-17       Impact factor: 2.882

8.  Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging.

Authors:  Paco E Bravo; Ganesh Raghu; David G Rosenthal; Shana Elman; Bradley J Petek; Laurie A Soine; Jeffrey H Maki; Kelley R Branch; Sofia C Masri; Kristen K Patton; James H Caldwell; Eric V Krieger
Journal:  Int J Cardiol       Date:  2017-03-10       Impact factor: 4.164

9.  Right ventricular sarcoidosis: is it time for updated diagnostic criteria?

Authors:  Kairav Vakil; Elina Minami; Daniel P Fishbein
Journal:  Tex Heart Inst J       Date:  2014-04-01

Review 10.  Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.

Authors:  G Cameron Coleman; Peter W Shaw; Pelbreton C Balfour; Jorge A Gonzalez; Christopher M Kramer; Amit R Patel; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.